Cytta Announces Advanced Connectivity with Compression and Encryption for Multiple Vertical New Vertical Markets to Be Serviced by Newly Combined Entity
LAS VEGAS, NV / ACCESSWIRE / October 2, 2014 / Cytta Corp.'s (OTCQB: CYCA), CEO Gary Campbell is very pleased to provide the following year end report to all shareholders and future investors hereby updating the Company's accelerating business operations, dramatically growing personnel and various new exciting partnership activities recently concluded in our September 30th 2014 Year End Period.
The most exciting and dramatic change for Cytta in the final quarter of the year has been our Agreement to merge our business with those of EraStar Inc. and EraStar Medical, Inc.; with the consummation and filing of an SEC definitive 8-K expected today. Of course, many of you are familiar with EraStar because of our earlier contractual relationship with them for the past nine months wherein they had contracted to provide various strategic consulting services to the Company. While these were only a part of their services, they were extremely well performed and a very productive and synergistic relationship began to grow between the two entities. While we were working closely together, the highly diverse and talented board of EraStar informed me they were seeking to become a public company themselves, in that they could raise capital at a parent level in order to remain very long term players with their respective clients.
It soon became clear that EraStar had numerous connections, interests, clients, prospects, and individuals who could rapidly move Cytta beyond our status as a technology company, rapidly launch us into the US marketplace and begin the sales and marketing of our unique disruptive and breakthrough healthcare products. Inherent in EraStar was the knowledge necessary to design these market introductions, generate the sales programs to penetrate the identified markets and aggressively launch the Cytta technology into these markets.
The initial market identified is the "Doctor Direct" program which supplies General practitioners with a way of creating residual income streams while providing far better care to their patients. It is our ardent belief that the combined Cytta / EraStar entity will become far bigger than the sum of the parts, with the capability of developing and investing in numerous exciting vertical markets.
Additionally, members of the Cytta team are able to supply EraStar with services and capabilities necessary in their everyday business of evaluating and advising their clients and potential clients. The technical, administrative and public company which the Cytta team possesses will allow EraStar to provide numerous additional and unique services to their extensive clients and interested entity base. Creating the public company, advising, consulting and forming enterprises of the future is EraStar's goal. We welcome Natalia Sokolova, David Flores, Taylor Meador, Melissa De Leon, Christian Dalsgaard, Cristian Marroquin, Jack Thompson, and Steve Luna to the Senior Advisor and executive team. We have built a formidable group who is extremely capable.
Speaking personally, it has been my profound pleasure to meet and work with the EraStar senior management team of Jens Dalsgaard, Jamison Moore, Steffan Dalsgaard, and Vanessa Luna. Having worked with this remarkable group of individuals for the past 9 months, it is my extreme pleasure to turn the day to day management of Cytta over to their very competent operational abilities.
Jens Dalsgaard as the Chairman and Co-CEO will bring his tireless brand of effort, energy and enthusiasm to running the combined Cytta/EraStar entity.
Steffan Dalsgaard as the Co-CEO and Director brings another level of professionalism and maturity to the elements of the business he controls. While still young for the position, I have no hesitation in saying that he will bring his tireless work efforts and thoughtful and enquiring mind to the position. Not to mention the best way of dealing with the youth markets are through the young.
Jamison Moore, EraStar Director, will continue to excel in his role as Chief Business Development Officer. "CBDO" Jamison will identify new potential business opportunities as well as lead the due-diligence process that follows each and every new prospect and client that comes through our doors.
Vanessa Luna will be assuming the role of President/ COO and Director of the combined entity and bring her world class operational skills and experience to the operations of the new entity. I personally look forward to her rollout of the "Doctor Direct" program and enjoy the verve and panache she brings to the development of the strategic plan for the Cytta Connect rollout.
Combining with EraStar will allow Cytta to utilize the Cytta Connect ecosystem in multiple vertical markets. Utilizing EraStar's capabilities and client technologies, we are now imagining real-time connectivity and transmission solutions through our Cytta Labs division at the behest of several different parties in multiple industries. Development work will soon commence in both the Healthcare and Oil & Gas verticals. We anticipate entering several more verticals where our technology will be paired with other industry leading monitoring technologies introduced to us by the rapidly growing EraStar Team.
Summary
The way forward for Cytta is clear. We are combining our abilities with those of EraStar. Collectively we will work to develop our unique data transmission platform to demonstrate corporate value in intellectual property, collaborative partnerships, as well as revenue and profits. To win in the market, Cytta will join with EraStar, identify forward thinking industrial organizations, channel distribution partners and creative technology joint venture programs to introduce our system and acquire new and exciting technologies to bring to the market to augment our sales and marketing operations.
Thank you for your ongoing support and the support given to the new management team. We all look forward to a successful 2015 Fiscal Year.
About EraStar, Inc.
EraStar, Inc. is a dynamic Las Vegas based marketing business that offers the following services: Comprehensive Marketing Strategies for Public and Private Institutions, Public Relations and Media Activities, Product Marketing, Support Services, Business Development Consulting, and Lead Generation. EraStar currently provides services to a variety of clients in a number of industries nationwide.
About EraStar Medical, Inc.
EraStar Medical Inc. (EMI) is a sub division; Nevada Corporation of EraStar Inc. a dynamic Las Vegas based marketing business. EraStar Medical Inc. creates a structure within its parent company that allows management to apply their advisory services and med-tech acquisitions specifically in the booming med-tech sector. EraStar Medical seeks to provide cost efficient technical strategies that will create superior healthcare outcomes for physicians and patients globally.
About Cytta Corp.
Cytta Corp. is an open source remote monitoring connectivity platform known for its highly scalable and secure Healthcare licensing solutions. We are now offering the Cytta Connect technology to the Oil & Gas industry and will make available our remote data capture highway that connects monitoring devices seamlessly to an Online Industrial Data Repository (IDR). Our remote data capture system works over our Special Purpose Network, a proprietary Global Mobile, Satellite, Wi-Fi open source network, and Cloud-based data repository that automatically connects all remote monitoring devices to Cytta's open source IDR creating real time communication for the Oil & Gas industry with world leading compression heretofore unavailable in the market.
Safe Harbor Statement
Forward-Looking Statements
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, the impact of any product liability or other adverse litigation, working capital and availability of capital, commercialization and technological difficulties, the impact of actions and events involving key customers, vendors, lenders, competitors, and other risks detailed in the Company's Form 10-K for the year ended September 30, 2013, and other subsequent Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release, the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will", and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward looking statements, whether as a result of future events, new information, or otherwise.
CONTACTS:
Mr. Gary Campbell, CEO
Office (702) 307-1680
Email: [email protected]
Website: www.Cytta.com
[email protected]
EraStar, Inc.
Ms. Vanessa Luna, COO
Las Vegas, NV 89141
702 480 9800 office
[email protected]
Website: www.EraStar.com
SOURCE: Cytta Corp.